Abstracts - faqs.org

Abstracts

Health

Search abstracts:
Abstracts » Health

Transplantation in first remission of acute myeloid leukemia

Article Abstract:

Bone marrow transplants may no longer be the most appropriate treatment for patients with acute myeloid leukemia who have a relapse following chemotherapy. Transplants were more effective than chemotherapy in the 1980s, but chemotherapy has improved since then. Also, researchers have discovered factors that influence an individual patient's prognosis. Consequently, patients with poor prognostic factors can be offered one treatment over another. Several studies have found that bone marrow transplants are no longer more effective than chemotherapy.

Author: Burnett, Alan K.
Publisher: Massachusetts Medical Society
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 1998
Editorial, Bone marrow, Bone marrow transplantation, Acute leukemia, Promyelocytic

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Hematopoietic growth factors and the future of therapeutic research on acute myeloid leukemia

Article Abstract:

More research is needed to determine whether patients with acute myeloid leukemia will benefit from treatment with hematopoietic growth factors such as granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor. These growth factors stimulate immature cells to mature. Some doctors believe they might also make cancer cells more sensitive to chemotherapy.

Author: Schiffer, Charles A.
Publisher: Massachusetts Medical Society
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 2003
Granulocyte colony-stimulating factor

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Prognostically useful gene-expression profiles in acute myeloid leukemia

Article Abstract:

A combination of methods must be used to classify the disease myeloid leukemia, which makes therapeutic decisions, and determine the prognosis. Gene-expression profiling allows a comprehensive classification of acute myeloid leukemia (AML) that includes previously identified genetically defined subgroups and a novel cluster with an adverse prognosis.

Author: Valk, Peter J.M., Verhaak, Roel G.W., Beijen, M. Antoinette, Erpelinck, Claudia A.J., Boer, Judith M.
Publisher: Massachusetts Medical Society
Publication Name: The New England Journal of Medicine
Subject: Health
ISSN: 0028-4793
Year: 2004
United States, Usage, Diagnosis, Identification and classification, Gene expression

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: Care and treatment, Acute myelocytic leukemia
Similar abstracts:
  • Abstracts: Transplantation immunology. Chronic graft-vs-host disease
  • Abstracts: Infection control: the role of the nurse. Florence of Arabia
  • Abstracts: Airway surface dehydration in cystic fibrosis: Pathogenesis and therapy. Pathogenesis and treatment of graft-versus-host disease after bone marrow transplant
  • Abstracts: Calorie restriction, aging, and cancer prevention: mechanisms of action and applicability to humans. Studying cancer families to identify kidney cancer genes
  • Abstracts: Ultrasound-enhanced systemic thrombolysis for acute ischemic stroke
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.